Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB―IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST)BONI, C; TISEO, M; LABIANCA, R et al.British journal of cancer. 2012, Vol 106, Num 4, pp 658-665, issn 0007-0920, 8 p.Article

Suppressive activity of acivicin on murine bone marrow hemopoietic progenitorsCASTELLO, G; MENCOBONI, M; LERZA, R et al.Anticancer research. 1992, Vol 12, Num 6B, pp 2181-2184, issn 0250-7005Conference Paper

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesotheliomaCERESOLI, G. L; ZUCALI, P. A; SOTO-PARRA, H et al.British journal of cancer. 2013, Vol 109, Num 3, pp 552-558, issn 0007-0920, 7 p.Article

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma : combined analysis of two phase II trialsCERESOLI, G. L; CASTAGNETO, B; SALAMINA, S et al.British journal of cancer. 2008, Vol 99, Num 1, pp 51-56, issn 0007-0920, 6 p.Article

Experimental comparative study on myelotoxicity of 4'-deoxy-4'-I-doxorubicin and of doxorubicinLERZA, R; BOGLIOLO, G; MENCOBONI, M et al.Chemotherapy (Basel). 1988, Vol 34, Num 4, pp 354-359, issn 0009-3157Article

Concurrent chemo-radiotherapy with taxotere and cisplatin in head and neck cancer : A feasibility studyMENCOBONI, M; REBELLA, L; TREDICI, S et al.Anticancer research. 2005, Vol 25, Num 6C, pp 4451-4454, issn 0250-7005, 4 p.Article

Hematotoxicity of 5-fluorouracil and α-interferon on the human normal hemopoietic progenitorsCASTELLO, G; MENCOBONI, M; LERZA, R et al.Anticancer research. 1993, Vol 13, Num 5A, pp 1477-1479, issn 0250-7005Article

Toxicity of vidarabine on hemopoietic progenitor cells in miceMENCOBONI, M; LERZA, R; BOGLIOLO, G et al.Chemotherapy (Basel). 1990, Vol 36, Num 3, pp 240-244, issn 0009-3157, 5 p.Article

Diltiazem does not increase the in vivo sensitivity of murine hemopoietic progenitor cells to doxorubicinLERZA, R; BOGLIOLO, G; SAVIANE, A et al.Life sciences (1973). 1988, Vol 42, Num 6, pp 651-658, issn 0024-3205Article

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter surveyCERESOLI, G. L; GROSSO, F; PICCOLINI, E et al.British journal of cancer. 2014, Vol 111, Num 2, pp 220-226, issn 0007-0920, 7 p.Article

Docetaxel pharmacokinetics with pre- and post-dialysis administration in a hemodyalized patientMENCOBONI, M; OLIVIERI, R; VANNOZZI, M. O et al.Chemotherapy (Basel). 2006, Vol 52, Num 3, pp 147-150, issn 0009-3157, 4 p.Article

Effects of docetaxel on the in vitro growth of human myeloid progenitorsBOTTA, M; ARBOSCELLO, E; LERZA, R et al.Anticancer research. 1999, Vol 19, Num 3A, pp 1855-1858, issn 0250-7005Article

Feasibility and toxicity of combination chemotherapy with ifosfamide, vinorelbine, cisplatin versus ifosfamide, vinorelbine in patients with advanced non small cell lung cancerMENCOBONI, M; LERZA, R; CASTELLO, G et al.Anticancer research. 1997, Vol 17, Num 4A, pp 2795-2798, issn 0250-7005Article

Cisplatin, 5-fluorouracil and alpha interferon in non small cell lung carcinoma : a toxicity studyCASTELLO, G; LERZA, L; MENCOBONI, M et al.Anticancer research. 1994, Vol 14, Num 2B, pp 621-625, issn 0250-7005Article

Azidothymidine-induced depression of murine hemopoietic progenitor cellsBOGLIOLO, G; LERZA, R; MENCOBONI, M et al.Experimental hematology. 1988, Vol 16, Num 11, pp 938-940, issn 0301-472XArticle

Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)CASTAGNETO, B; BOTTA, M; GALBUSERA, V et al.Annals of oncology. 2008, Vol 19, Num 2, pp 370-373, issn 0923-7534, 4 p.Article

Maintenance Therapy with Gefitinib after First-line Chemotherapy in Patients Affected by Advanced Non-small Cell Lung CancerMENCOBONI, M; BERGAGLIO, M; SERRA, M et al.Anticancer research. 2007, Vol 27, Num 6C, pp 4425-4429, issn 0250-7005, 5 p.Article

Effect of chemotherapy on somatostatin receptor detection with octreotide scintigraphy in hormone-refractory prostate cancer patientsMENCOBONI, M; TREDICI, S; REBELLA, L et al.Anticancer research. 2006, Vol 26, Num 3B, pp 2233-2235, issn 0250-7005, 3 p.Article

Toxicity on human hemopoietic progenitors of 2'-2'-difluoro-2'deoxycytidine (gemcitabine)BOTTA, M; CASTELLO, G; BALLARINO, P et al.Anticancer research. 1998, Vol 18, Num 2A, pp 1037-1042, issn 0250-7005Article

Production of tumor necrosis factor and granulocyte colony stimulating factor by bone marrow accessory cells in myelodysplastic patientsMENCOBONI, M; CASTELLO, G; LERZA, R et al.European journal of haematology. 1996, Vol 56, Num 3, pp 148-152, issn 0902-4441Article

Protective effect on cisplatin hematotoxicity by procaine hydrochlorideESPOSITO, M; LERZA, R; MENCOBONI, M et al.Cancer letters. 1992, Vol 64, Num 1, pp 55-60, issn 0304-3835Article

Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trialMURIALDO, R; BERTOLOTTI, F; PARODI, M et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 4, pp 1009-1016, issn 0344-5704, 8 p.Article

Advanced colorectal cancer : Quality of life and toxicity in patients after weekly 24-hour continuous infusions of biomodulated 5-fluorouracilBOGLIOLO, G; PANNACCIULLI, I; DESALVO, L et al.Anticancer research. 2000, Vol 20, Num 1B, pp 501-504, issn 0250-7005Article

Cisplatin inhibits erythroid committed progenitor (BFU-E) mobilization in peripheral bloodPANNACCIULLI, I; CASTELLO, G; LERZA, R et al.European journal of haematology. 1998, Vol 61, Num 1, pp 65-70, issn 0902-4441Article

In vitro toxicity of a 3'-azido-3'-deoxythymidine and hydroxyurea combination on normal myeloid progenitorsLERZA, R; CASTELLO, G; BALLARINO, P et al.Anticancer research. 1998, Vol 18, Num 4A, pp 2755-2758, issn 0250-7005Article